Pancreagen

Pancreagen is a Pancreatic Peptide Bioregulator supplied for laboratory research. Pancreatic bioregulator studied in vitro for exocrine and endocrine cell function pathway modeling and insulin signaling mechanism research.

Pancreagen (Lys-Glu-Asp-Trp) is a pancreatic peptide bioregulator studied for exocrine and endocrine pancreatic cell function and insulin-related signaling.

Pancreagen is manufactured synthetically, not extracted from the pancreas. Its sequence (Lys-Glu-Asp-Trp) is based on a regulatory peptide associated with pancreatic tissue, and it is studied for pancreatic cell signaling.

Pancreagen is supplied as a lyophilized (freeze-dried) powder — a dehydrated form that keeps the peptide stable during shipping and storage. In the laboratory it is reconstituted (returned to liquid form) using a solvent such as bacteriostatic water, added slowly against the side of the vial, which is then swirled gently — never shaken — until the powder fully dissolves. All handling is for in vitro research use only.

Store the lyophilized Pancreagen powder at -20°C, protected from light and moisture, where it remains stable long-term. Once reconstituted, keep it refrigerated (2-8°C) and use it within the timeframe appropriate for your research protocol.

Every batch of Pancreagen is produced to a purity of 99% or higher. Purity and molecular identity are verified using standard analytical methods — high-performance liquid chromatography (HPLC) to measure purity, and mass spectrometry (MS) to confirm the peptide's molecular weight.